Use of the theory of planned behavior to explain HRT decisions

American Journal of Health Behavior

Volumn 27, Issue 4, 2003, Pages 445-455

  Spatz, Barbara A ^a   Thombs, Dennis L ^c   Byrne, T Jean ^c   Page, Betsy J ^b  

^a Cuyahoga Community College   (United States)

^b KENT STATE UNIVERSITY   (United States)

^c NONE

Author keywords

Hormone replacement therapy; Theory of planned behavior

Indexed keywords

ARTICLE; ATTITUDE; BEHAVIOR; DECISION MAKING; DOCTOR PATIENT RELATION; FEMALE; HEALTH SURVEY; HORMONE SUBSTITUTION; HUMAN; PATIENT EDUCATION; PERCEPTION; RISK BENEFIT ANALYSIS;

EID: 0141576505     PISSN: 10873244     EISSN: None     Source Type: Journal    
DOI: 10.5993/AJHB.27.4.16     Document Type: Article

References (50)

1. North American Menopause Society. About menopause: statistical facts and figures (online). Available: http:/www.menopause.org/aboutm/stats.html. Accessed May 15, 2002.
2. Barrett-Connor E, Hendrix S, Ettinger B, et al. Best clinical practices. In Wenger NK, Paoletti R, Lenfant CJM, Pinn VW, (Eds). The International Position Paper on Women's Health and Menopause: A Comprehensive Approach (online). Available: http:/www4.od.nih.gov/onwh. Accessed May 16, 2002.
3. Jolleys J, Olesen F. A comparative study of prescribing of hormone replacement therapy in USA and Europe. Maturitas. 1996;23:47-53.
4. Kaufert P. The social and cultural context of menopause. Maturitas. 1996;23:169-180.
5. Carolan M. Beyond deficiency: broadening the view of menopause. J Appl Gerontol. 1994;13 (2);193-205.
6. Chirawatkul S, Manderson L. Perceptions of menopause in northeast Thailand. Social Science and Medicine. 1994;39:1339-1348.
7. Chornesky A. Multicultural perspectives on menopause and the climacteric. Affilia. 1998;13(1):31-46.
8. Clark S, McCarthy M, McNamee D. Hormone replacement therapy. Lancet. 1999:354(9173):152-155.
9. Lock M. Ambiguities of aging: Japanese experience and perceptions of menopause. Culture Medicine and Psychiatry. 1986;10:23-46.
10. Barile L. Theories of menopause: brief comparative synopsis. Journal of Psychosocial Nursing. 1997;35(2):36-39.
11. Li S, Carlson E, Snyder D, et al. Perspectives on menopause. Clin Nurse Spec. 1995;9(3):145-148.
12. Engebretson J, Wardell D. Perimenopausal women's alienation J Holist Nurs. 1997;15(3):254-270.
13. Schairer C, Lubin J, Troisi R, et al. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA. 2000;283(4):485-491.
14. Willett W, Colditz G, Stampfer M. Postmenopausal estrogens - opposed, unopposed, or none of the above. JAMA. 2000;283(4):534-535.
15. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-333.
16. Vastag B. Hormone replacement therapy falls out of favor with expert committee JAMA. 2002;287(15):1923-1924.
17. Abraham S, Llewellyn-Jones D, Perz J. Changes in Australian women's perception of the menopause and menopausal symptoms before and after climacteric. Maturitas. 1994;20:121-128.
18. Bastian L, Couchman G, Rimer B, McBride C, et al. Perceptions of menopausal stage and patterns of hormone replacement therapy use. J Womens Health. 1997;6(4):467-475.
19. Berman R, Epstein R, Lydick E. Risk factors associated with women's compliance with estrogen replacement therapy J Womens Health. 1997;6(2):219-225.
20. Brett K, Madans J. Differences in use of postmenopausal hormone replacement therapy by black and white women. Menopause. 1997;4(2):66-70.
21. Cauley J, Cummings S, Black D, et al. Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol. 1990;163(5 Part 1):1438-1444.
22. D'epiro N. HRT: new data, continuing controversies. Patient Care. 1998;December15:92-109.
23. Egeland G, Matthews K, Kuller L, et al. Characteristics of noncontraceptive hormone users. Prey Med. 1988; 17:403-411.
24. Groeneveld F, Bareman F, Barentsen R, et al. Determinants of first prescription of hormone replacement therapy. A follow-up study among 1689 women aged 45-60 years. Maturitas. 1998;20:81-89.
25. Keating N, Cleary P, Rossi A, et al. Use of hormone replacement therapy by postmenopausal women in the United States. Ann Intern Med. 1999;130:545-553.
26. Lichtman R. Perimenopausal and postmenopause hormone replacement therapy. Part 1. An update of the literature on benefits and risks. J Nurse Midwifery. 1996;41(1):3-28.
27. Ghali W, Freund K, Boss R, et al. Menopausal hormone therapy: physician awareness of patient attitudes. Am J Med. 1997;103:3-10.
28. DeMasters J. Women and the hormone replacement therapy decision: a study of concerns, values and behaviors using a multiattribute utility model (Doctoral dissertation, University of Missouri-Saint Louis). Dissertation Abstracts International. 1999;59/11:5784.
29. Jeffe D, Freiman M, Fisher E. Women's reasons for using postmenopausal hormone replacement therapy: preventive medicine or therapeutic aid? Menopause. 1996;3(2):106-116.
30. Marmoreo J, Brown J, Batty H, et al. Hormone replacement therapy: determinants of women's decisions. Patient Educ Couns. 1998;33:289-298.
31. Newton K, LaCroix A, Leveille S, et al. Women's beliefs and decisions about hormone replacement therapy. J Wornens Health. 1997;6:459-465.
32. Stafford R, Saglam D, Causino N, et al. Low rates of hormone replacement in visits to United States primary care physicians. Am J Obstet Gynecol. 1997;177:381-387.
33. Walsh J, Brown J, Rubin S, et al. Postmenopausal hormone therapy: factors influencing women's decision making. Menopause. 1997;4(1):39-45.
34. Morrison K. Women's knowledge of menopause and estrogen replacement therapy: a survey conducted in Alaska (Doctoral dissertation, The Union Institute). Dissertation Abstracts International. 1993;B55(02):601. (University Microfilms No. AAT 9410248).
35. Ruck V. Knowledge of hormone replacement therapy's risk and benefits, its cardioprotective properties and the likelihood to use hormone replacement therapy (Master's thesis, Michigan State University. Masters Abstracts International. 1996;35(05):1382. (University Microfilms No. AAT1385091).
36. Jensen L, Hilden J. Sociological and behavioural characteristics of perimenopausal women with an express attitude to hormone substitution therapy. Maturitas. 1996; 23(1):73-83.
37. Liao K, Hunter M. Preparation for menopause: prospective evaluation of a health education intervention for mid-aged women. Maturitas. 1998:29:215-224.
38. Griffiths F. Women's control and choice regarding HRT. Social Science and Medicine. 1999;49:469-481.
39. Halbert D, Lloyd T, Rollings N, et al. Hormone replacement therapy usage: a 10 year experience of a solo practitioner. Maturitas. 1998;29:67-73.
40. Prue C. Exploratory research of the factors that influence a woman's decision regarding hormone replacement therapy (Doctoral dissertation, University of Maryland at College Park). Dissertation Abstracts International. 1998;A59(06):1928. (University Microfilms No. AAT 9836466).
41. Quine L, Rubin R. Attitude, subjective norm and perceived behavioural control as predictors of women's intentions to take hormone replacement therapy. British Journal of Health Psychology. 1997;2(Part 3):199-216.
42. Lauver D, Stettersten L, Marten S, et al. Explaining women's intentions and use of hormones with menopause. Research in Nursing and Health. 1999;22:309-320.
43. Grisso J, Freeman E, Maurin E, et al. Racial differences in menopause information and the experience of hot flashes. J Gen Intern Med. 1999:14(2):98-103.
44. Logothetis M. Disease or development: women's perceptions of menopause and the need for hormone replacement therapy. In Callahan JC (Ed). Menopause: A Midlife Passage. Bloomington/Indianapolis: University Press 1993:124-135.
45. Miles T, Malik K. Menopause and African-American women: clinical and research issues. Exp Gerontol. 1994;29(3/4):511-581.
46. Nicholson W, Brown A, Gathe J, et al. Hormone replacement therapy for African American women: missed opportunities for effective intervention. Menopause. 1999;6(2):147-155.
47. US Department of Health and Human Services. Healthy People 2010: Understanding and Improving Health (on-line).Available: http://web.health.gov/healthypeople. Accessed August 5, 2002.
48. Col N, Eckman M, Karas RH, et al. Patient-specific decisions about hormone replacement therapy in postmenopausal women. JAMA. 1997; 277(14):1140-1147.
49. Grodstein F, Stampfer M, Manson J, et al. Postmenopausal hormone therapy and mortality. N Engl J Med. 1997;336(25):1769-1775.
50. Godin G, Kok G. The theory of planned behavior: a review of its applications to health-related behaviors. Am J Health Promot. 1996;11(2):87-98.